Hening Lin to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Hening Lin has written about Dose-Response Relationship, Drug.
Connection Strength
0.320
-
Direct Comparison of SIRT2 Inhibitors: Potency, Specificity, Activity-Dependent Inhibition, and On-Target Anticancer Activities. ChemMedChem. 2018 09 19; 13(18):1890-1894.
Score: 0.107
-
An improved fluorogenic assay for SIRT1, SIRT2, and SIRT3. Org Biomol Chem. 2016 Feb 21; 14(7):2186-90.
Score: 0.089
-
Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer. J Med Chem. 2021 10 28; 64(20):15280-15296.
Score: 0.033
-
High-Throughput Screening Identifies Ascorbyl Palmitate as a SIRT2 Deacetylase and Defatty-Acylase Inhibitor. ChemMedChem. 2021 11 19; 16(22):3484-3494.
Score: 0.033
-
Cysteine derivatives as acetyl lysine mimics to inhibit zinc-dependent histone deacetylases for treating cancer. Eur J Med Chem. 2021 Dec 05; 225:113799.
Score: 0.033
-
HDAC1 Governs Iron Homeostasis Independent of Histone Deacetylation in Iron-Overload Murine Models. Antioxid Redox Signal. 2018 05 01; 28(13):1224-1237.
Score: 0.025